|
ZNF449 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04680000001522E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08419999999654E-05 |
| Normal-vs-Stage2 |
8.735300E-03 |
| Normal-vs-Stage3 |
8.18279999981186E-07 |
| Normal-vs-Stage4 |
2.91119999995537E-06 |
| Stage1-vs-Stage2 |
4.504200E-01 |
| Stage1-vs-Stage3 |
2.324000E-01 |
| Stage1-vs-Stage4 |
1.523630E-01 |
| Stage2-vs-Stage3 |
1.321830E-01 |
| Stage2-vs-Stage4 |
9.165800E-02 |
| Stage3-vs-Stage4 |
6.110800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.14799999956428E-07 |
| Normal-vs-AfricanAmerican |
3.801100E-03 |
| Normal-vs-Asian |
1.792290E-02 |
| Caucasian-vs-AfricanAmerican |
7.568400E-01 |
| Caucasian-vs-Asian |
1.248400E-01 |
| AfricanAmerican-vs-Asian |
4.973800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.301470E-03 |
| Normal-vs-Female |
1.2817999994752E-07 |
| Male-vs-Female |
1.299420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.027210E-04 |
| Normal-vs-Age(41-60Yrs) |
1.50131999999692E-05 |
| Normal-vs-Age(61-80Yrs) |
2.86620000000681E-06 |
| Normal-vs-Age(81-100Yrs) |
6.438500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.539000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.659200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.954400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.119800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.672400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.375200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.93019999989086E-07 |
| Classical-VS-Follicular |
8.696400E-01 |
| Classical-VS-Other |
8.565800E-01 |
| Classical-VS-Normal |
3.69020000000608E-05 |
| Tall-VS-Follicular |
8.36660000000933E-05 |
| Tall-VS-Other |
3.269600E-01 |
| Tall-VS-Normal |
5.06670261302133E-11 |
| Follicular-VS-Other |
8.827200E-01 |
| Follicular-VS-Normal |
6.832600E-04 |
| Other-VS-Normal |
4.311400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.46109999996391E-06 |
| Normal-vs-N1 |
3.423600E-02 |
| N0-vs-N1 |
2.810400E-01 |
|
|
